Share：
Share this content in WeChat
X
[Chinese][PDF]4101
• Review •
Research progress of radiomics in endometrial cancer
DING Sixuan  MENG Huan  YIN Xiaoping 

Cite this article as: DING S X, MENG H, YIN X P. Research progress of radiomics in endometrial cancer[J]. Chin J Magn Reson Imaging, 2023, 14(4): 188-192. DOI:10.12015/issn.1674-8034.2023.04.033.


[Abstract] Endometrial cancer is one of the most common gynecologic malignancies, and its treatment relies on accurate preoperative imaging and clinical evaluation. Radiomics transforms image information into intuitive data to reflect tumor internal heterogeneity by extracting quantitative features from medical images with high throughput. MRI-based radiomics can perform preoperative pre-assessment of patients with endometrial cancer non-invasively and accurately, helping clinicians to choose the appropriate treatment plan for patients. This article aims to introduce the basic concepts and processes of radiomics, review the current status of radiomics research for endometrial cancer in the fields of risk stratification, histopathological grade, myometrial invasion depth, cervical space invasion, lymphovascular space invasion, lymph node metastasis, prognosis and differential diagnosis, and make a preliminary prospect for future research, in order to provide imaging guidance value for the precise diagnosis and treatment of endometrial cancer in clinical practice.
[Keywords] endometrial cancer；risk stratification；differential diagnosis；precision diagnosis and treatment；radiomics；magnetic resonance imaging

DING Sixuan1, 2   MENG Huan1, 2   YIN Xiaoping1, 2*  

1 Department of Radiology, Affiliated Hospital of Hebei University, Baoding 071000, China

2 Hebei Key Laboratory of Precise Imaging of Inflammation Related Tumors, Baoding 071000, China

Corresponding author: Yin XP, E-mail: yinxiaoping78@sina.com

Conflicts of interest   None.

ACKNOWLEDGMENTS Science and Technology Program of Baoding, China (No. 2141ZF132); Outstanding Young Scientific Research and Innovation Team of Hebei University (No. 605020521007).
Received  2022-11-18
Accepted  2023-04-05
DOI: 10.12015/issn.1674-8034.2023.04.033
Cite this article as: DING S X, MENG H, YIN X P. Research progress of radiomics in endometrial cancer[J]. Chin J Magn Reson Imaging, 2023, 14(4): 188-192. DOI:10.12015/issn.1674-8034.2023.04.033.

[1]
SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2016[J]. CA Cancer J Clin, 2016, 66(1): 7-30. DOI: 10.3322/caac.21332.
[2]
KOKTS-PORIETIS R L, ELMRAYED S, BRENNER D R, et al. Obesity and mortality among endometrial cancer survivors: a systematic review and meta-analysis[J/OL]. Obes Rev, 2021, 22(12): e13337 [2022-10-20]. https://pubmed.ncbi.nlm.nih.gov/34476900. DOI: 10.1111/obr.13337.
[3]
CROSBIE E J, KITSON S J, MCALPINE J N, et al. Endometrial cancer[J]. Lancet, 2022, 399(10333): 1412-1428. DOI: 10.1016/S0140-6736(22)00323-3.
[4]
MAHESHWARI E, NOUGARET S, STEIN E B, et al. Update on MRI in evaluation and treatment of endometrial cancer[J]. Radiographics, 2022, 42(7): 2112-2130. DOI: 10.1148/rg.220070.
[5]
NOUGARET S, HORTA M, SALA E, et al. Endometrial cancer MRI staging: updated guidelines of the European society of urogenital radiology[J]. Eur Radiol, 2019, 29(2): 792-805. DOI: 10.1007/s00330-018-5515-y.
[6]
SALEH M, VIRARKAR M, BHOSALE P, et al. Endometrial cancer, the current international federation of gynecology and obstetrics staging system, and the role of imaging[J]. J Comput Assist Tomogr, 2020, 44(5): 714-729. DOI: 10.1097/RCT.0000000000001025.
[7]
OTERO-GARCÍA M M, MESA-ÁLVAREZ A, NIKOLIC O, et al. Role of MRI in staging and follow-up of endometrial and cervical cancer: pitfalls and mimickers[J/OL]. Insights Imaging, 2019, 10(1): 19 [2022-10-20]. https://pubmed.ncbi.nlm.nih.gov/30758678/. DOI: 10.1186/s13244-019-0696-8.
[8]
WINARTO H, HABIBURRAHMAN M, SIREGAR T P, et al. Magnetic resonance imaging pitfalls in determining myometrial invasion in stage I endometrial cancer: a case report and literature review[J]. Radiol Case Rep, 2022, 17(8): 2680-2688. DOI: 10.1016/j.radcr.2022.05.021.
[9]
PARK J E, KIM D, KIM H S, et al. Quality of science and reporting of radiomics in oncologic studies: room for improvement according to radiomics quality score and TRIPOD statement[J]. Eur Radiol, 2020, 30(1): 523-536. DOI: 10.1007/s00330-019-06360-z.
[10]
SCAPICCHIO C, GABELLONI M, BARUCCI A, et al. A deep look into radiomics[J]. Radiol Med, 2021, 126(10): 1296-1311. DOI: 10.1007/s11547-021-01389-x.
[11]
LAMBIN P, LEIJENAAR R T H, DEIST T M, et al. Radiomics: the bridge between medical imaging and personalized medicine[J]. Nat Rev Clin Oncol, 2017, 14(12): 749-762. DOI: 10.1038/nrclinonc.2017.141.
[12]
GILLIES R J, KINAHAN P E, HRICAK H. Radiomics: images are more than pictures, they are data[J]. Radiology, 2016, 278(2): 563-577. DOI: 10.1148/radiol.2015151169.
[13]
GUIOT J, VAIDYANATHAN A, DEPREZ L, et al. A review in radiomics: making personalized medicine a reality via routine imaging[J]. Med Res Rev, 2022, 42(1): 426-440. DOI: 10.1002/med.21846.
[14]
MAYERHOEFER M E, MATERKA A, LANGS G, et al. Introduction to radiomics[J]. J Nucl Med, 2020, 61(4): 488-495. DOI: 10.2967/jnumed.118.222893.
[15]
LIU Z Y, WANG S, DONG D, et al. The applications of radiomics in precision diagnosis and treatment of oncology: opportunities and challenges[J]. Theranostics, 2019, 9(5): 1303-1322. DOI: 10.7150/thno.30309.
[16]
HESAMIAN M H, JIA W J, HE X J, et al. Deep learning techniques for medical image segmentation: achievements and challenges[J]. J Digit Imaging, 2019, 32(4): 582-596. DOI: 10.1007/s10278-019-00227-x.
[17]
ROGERS W, THULASI SEETHA S, REFAEE T A G, et al. Radiomics: from qualitative to quantitative imaging[J/OL]. Br J Radiol, 2020, 93(1108): 20190948 [2022-10-20]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362913. DOI: 10.1259/bjr.20190948.
[18]
COLOMBO N, CREUTZBERG C, AMANT F, et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up[J]. Ann Oncol, 2016, 27(1): 16-41. DOI: 10.1093/annonc/mdv484.
[19]
AMANT F, MIRZA M R, KOSKAS M, et al. Cancer of the corpus uteri[J]. Int J Gynaecol Obstet, 2018, 143(Suppl 2): 37-50. DOI: 10.1002/ijgo.12612.
[20]
HAMILTON C A, POTHURI B, AREND R C, et al. Endometrial cancer: a society of gynecologic oncology evidence-based review and recommendations[J]. Gynecol Oncol, 2021, 160(3): 817-826. DOI: 10.1016/j.ygyno.2020.12.021.
[21]
NWACHUKWU C, BASKOVIC M, VON EYBEN R, et al. Recurrence risk factors in stage IA grade 1 endometrial cancer[J/OL]. J Gynecol Oncol, 2021, 32(2): e22 [2022-10-20]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930446. DOI: 10.3802/jgo.2021.32.e22.
[22]
SATOSHI O, YUKI H, MIZUHO N, et al. Radiomic machine learning for pretreatment assessment of prognostic risk factors for endometrial cancer and its effects on radiologists' decisions of deep myometrial invasion[J]. Magn Reson Imaging, 2022, 85: 161-167. DOI: 10.1016/j.mri.2021.10.024.
[23]
LEFEBVRE T L, UENO Y, DOHAN A, et al. Development and validation of multiparametric MRI-based radiomics models for preoperative risk stratification of endometrial cancer[J]. Radiology, 2022, 305(2): 375-386. DOI: 10.1148/radiol.212873.
[24]
ZHANG K Y, ZHANG Y, FANG X, et al. Nomograms of combining apparent diffusion coefficient value and radiomics for preoperative risk evaluation in endometrial carcinoma[J/OL]. Front Oncol, 2021, 11: 705456 [2022-09-30]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353445. DOI: 10.3389/fonc.2021.705456.
[25]
YAN B C, LI Y, MA F H, et al. Preoperative assessment for high-risk endometrial cancer by developing an MRI- and clinical-based radiomics nomogram: a multicenter study[J]. J Magn Reson Imaging, 2020, 52(6): 1872-1882. DOI: 10.1002/jmri.27289.
[26]
MAINENTI P P, STANZIONE A, CUOCOLO R, et al. MRI radiomics: a machine learning approach for the risk stratification of endometrial cancer patients[J/OL]. Eur J Radiol, 2022, 149: 110226 [2022-09-30]. https://pubmed.ncbi.nlm.nih.gov/35231806. DOI: 10.1016/j.ejrad.2022.110226.
[27]
PHELIPPEAU J, CANLORBE G, BENDIFALLAH S, et al. Preoperative diagnosis of tumor grade and type in endometrial cancer by pipelle sampling and hysteroscopy: results of a French study[J]. Surg Oncol, 2016, 25(4): 370-377. DOI: 10.1016/j.suronc.2016.08.004.
[28]
BEREBY-KAHANE M, DAUTRY R, MATZNCR-LOBER E, et al. Prediction of tumor grade and lymphovascular space invasion in endometrial adenocarcinoma with MR imaging-based radiomic analysis[J]. Diagn Interv Imaging, 2020, 101(6): 401-411. DOI: 10.1016/j.diii.2020.01.003.
[29]
ZHENG T, YANG L S, DU J, et al. Combination analysis of a radiomics-based predictive model with clinical indicators for the preoperative assessment of histological grade in endometrial carcinoma[J/OL]. Front Oncol, 2021, 11: 582495 [2022-09-30]. https://pubmed.ncbi.nlm.nih.gov/34235069. DOI: 10.3389/fonc.2021.582495.
[30]
LARSON D M, CONNOR G P, BROSTE S K, et al. Prognostic significance of gross myometrial invasion with endometrial cancer[J]. Obstet Gynecol, 1996, 88(3): 394-398. DOI: 10.1016/0029-7844(96)00161-5.
[31]
CAI S L, ZHANG H, CHEN X J, et al. MR volumetry in predicting the aggressiveness of endometrioid adenocarcinoma: correlation with final pathological results[J]. Acta Radiol, 2020, 61(5): 705-713. DOI: 10.1177/0284185119877331.
[32]
HAN Y Q, XU H, MING Y, et al. Predicting myometrial invasion in endometrial cancer based on whole-uterine magnetic resonance radiomics[J]. J Cancer Res Ther, 2020, 16(7): 1648-1655. DOI: 10.4103/jcrt.JCRT_1393_20.
[33]
ZHAO M L, WEN F, SHI J X, et al. MRI-based radiomics nomogram for the preoperative prediction of deep myometrial invasion of FIGO stage I endometrial carcinoma[J]. Med Phys, 2022, 49(10): 6505-6516. DOI: 10.1002/mp.15835.
[34]
RODRÍGUEZ-ORTEGA A, ALEGRE A, LAGO V, et al. Machine learning-based integration of prognostic magnetic resonance imaging biomarkers for myometrial invasion stratification in endometrial cancer[J]. J Magn Reson Imaging, 2021, 54(3): 987-995. DOI: 10.1002/jmri.27625.
[35]
STANZIONE A, CUOCOLO R, DEL GROSSO R, et al. Deep myometrial infiltration of endometrial cancer on MRI: a radiomics-powered machine learning pilot study[J]. Acad Radiol, 2021, 28(5): 737-744. DOI: 10.1016/j.acra.2020.02.028.
[36]
Gynecologic Oncology Professional Committee of Chinese Anti-Cancer Association. Guidelines for diagnosis and treatment of endometrial cancer (2021 edition)[J]. China Oncol, 2021, 31(6): 501-512. DOI: 10.19401/j.cnki.1007-3639.2021.06.08.
[37]
KIM S I, YOON J H, LEE S J, et al. Prediction of lymphovascular space invasion in patients with endometrial cancer[J]. Int J Med Sci, 2021, 18(13): 2828-2834. DOI: 10.7150/ijms.60718.
[38]
FANG R Q, CHEN X P, ZHANG G W, et al. Radiomics nomogram for prediction of cervical stromal invasion in endometrial cancer[J]. J Clin Radiol, 2022, 41(6): 1105-1109. DOI: 10.13437/j.cnki.jcr.2022.06.032.
[39]
PENG Y J, LIU X W, TANG X, et al. Preoperative predicting lymphov-ascular space invasion in endometrial carcinoma by nomogram based on mpMRI radiomics[J]. Chin J Magn Reson Imaging, 2022, 13(7): 61-67. DOI: 10.12015/issn.1674-8034.2022.07.011.
[40]
LUO Y, MEI D D, GONG J S, et al. Multiparametric MRI-based radiomics nomogram for predicting lymphovascular space invasion in endometrial carcinoma[J]. J Magn Reson Imaging, 2020, 52(4): 1257-1262. DOI: 10.1002/jmri.27142.
[41]
BI Q, CHEN Y H, WU K H, et al. The diagnostic value of MRI for preoperative staging in patients with endometrial cancer: a meta-analysis[J]. Acad Radiol, 2020, 27(7): 960-968. DOI: 10.1016/j.acra.2019.09.018.
[42]
YAN B C, LI Y, MA F H, et al. Radiologists with MRI-based radiomics aids to predict the pelvic lymph node metastasis in endometrial cancer: a multicenter study[J]. Eur Radiol, 2021, 31(1): 411-422. DOI: 10.1007/s00330-020-07099-8.
[43]
CONNOR E V, ROSE P G. Management strategies for recurrent endometrial cancer[J]. Expert Rev Anticancer Ther, 2018, 18(9): 873-885. DOI: 10.1080/14737140.2018.1491311.
[44]
ZHANG K Y, ZHANG Y, FANG X, et al. MRI-based radiomics and ADC values are related to recurrence of endometrial carcinoma: a preliminary analysis[J/OL]. BMC Cancer, 2021, 21(1): 1266 [2022-10-20]. https://pubmed.ncbi.nlm.nih.gov/34819042/. DOI: 10.1186/s12885-021-08988-x.
[45]
JACOB H, DYBVIK J A, YTRE-HAUGE S, et al. An MRI-based radiomic prognostic index predicts poor outcome and specific genetic alterations in endometrial cancer[J/OL]. J Clin Med, 2021, 10(3): 538 [2022-10-20]. https://pubmed.ncbi.nlm.nih.gov/33540589/. DOI: 10.3390/jcm10030538.
[46]
LECOINTRE L, DANA J, LODI M, et al. Artificial intelligence-based radiomics models in endometrial cancer: a systematic review[J]. Eur J Surg Oncol, 2021, 47(11): 2734-2741. DOI: 10.1016/j.ejso.2021.06.023.
[47]
CHEN X J, WANG X, GAN M, et al. MRI-based radiomics model for distinguishing endometrial carcinoma from benign mimics: a multicenter study[J/OL]. Eur J Radiol, 2022, 146: 110072 [2022-09-30]. https://pubmed.ncbi.nlm.nih.gov/34861530. DOI: 10.1016/j.ejrad.2021.110072.
[48]
RAKHA E, WONG S C, SOOMRO I, et al. Clinical outcome of atypical endometrial hyperplasia diagnosed on an endometrial biopsy: institutional experience and review of literature[J]. Am J Surg Pathol, 2012, 36(11): 1683-1690. DOI: 10.1097/PAS.0b013e31825dd4ff.
[49]
ZHANG J Y, ZHANG Q, WANG T T, et al. Multimodal MRI-based radiomics-clinical model for preoperatively differentiating concurrent endometrial carcinoma from atypical endometrial hyperplasia[J/OL]. Front Oncol, 2022, 12: 887546 [2022-09-30]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186045. DOI: 10.3389/fonc.2022.887546.

PREV Research progress of MRI in activity evaluation and follow-up of perianal fistulizing Crohn,s disease
NEXT Clinical value and research progress of MRI risk stratification in the Ovarian-Adnexal Reporting and Data System
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn